DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$56.1B
1-Year Return
19.33%
This Quarter Return
+13.6%
1 Year Return
+19.33%
3 Year Return
+93.16%
5 Year Return
+155.59%
10 Year Return
+349.91%
AUM
$26.6B
AUM Growth
+$4.1B
(+18%)
Cap. Flow
+$1.34B
Cap. Flow
% of AUM
5.04%
Top 10 Holdings %
Top 10 Hldgs %
24.22%
Holding
1,386
New
198
Increased
571
Reduced
426
Closed
55
Top Buys
| 1 |
Abbott
ABT
|
$117M |
| 2 |
Snowflake
SNOW
|
$83.3M |
| 3 |
TE Connectivity
TEL
|
$67.3M |
| 4 |
Microsoft
MSFT
|
$66.1M |
| 5 |
Zoom
ZM
|
$59.3M |
Top Sells
| 1 |
Alibaba
BABA
|
$53.6M |
| 2 |
Intuitive Surgical
ISRG
|
$52.8M |
| 3 |
SPLK
Splunk Inc
SPLK
|
$51.4M |
| 4 |
AT&T
T
|
$38.7M |
| 5 |
Equinix
EQIX
|
$38.5M |
Sector Composition
| 1 | Technology | 24.53% |
| 2 | Healthcare | 16.41% |
| 3 | Financials | 11.42% |
| 4 | Communication Services | 10.25% |
| 5 | Consumer Discretionary | 8.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Caesarstone
CSTE
$48.7M
| $385K | ﹤0.01% |
29,838
| – | – |
|
1077
Avidity Biosciences
RNA
$6.48B
| $384K | ﹤0.01% |
+14,000
| New | +$384K |
|
1078
Adverum Biotechnologies
ADVM
$73.9M
| $380K | ﹤0.01% |
+3,250
| New | +$380K |
|
1079
Passage Bio
PASG
$22.8M
| $380K | ﹤0.01% |
+715
| New | +$380K |
|
1080
Charles River Laboratories
CRL
$8.07B
| $373K | ﹤0.01% |
+1,500
| New | +$373K |
|
1081
GDS Holdings
GDS
$6.35B
| $372K | ﹤0.01% |
4,115
+835
| +25% | +$75.5K |
|
1082
Melco Resorts & Entertainment
MLCO
$3.8B
| $370K | ﹤0.01% |
20,070
+2,553
| +15% | +$47.1K |
|
|
AMTI
1083
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
| $370K | ﹤0.01% |
+11,000
| New | +$370K |
|
|
EPZM
1084
DELISTED
Epizyme, Inc
EPZM
| $370K | ﹤0.01% |
32,300
+11,400
| +55% | +$131K |
|
|
PFPT
1085
DELISTED
Proofpoint, Inc.
PFPT
| $368K | ﹤0.01% |
2,800
-2,600
| -48% | -$342K |
|
1086
MacroGenics
MGNX
$126M
| $363K | ﹤0.01% |
16,200
+6,200
| +62% | +$139K |
|
1087
Compugen
CGEN
$134M
| $362K | ﹤0.01% |
30,000
| – | – |
|
|
ZGNX
1088
DELISTED
Zogenix, Inc.
ZGNX
| $362K | ﹤0.01% |
18,600
+7,000
| +60% | +$136K |
|
1089
Krystal Biotech
KRYS
$4.35B
| $361K | ﹤0.01% |
+6,400
| New | +$361K |
|
1090
Radware
RDWR
$1.07B
| $359K | ﹤0.01% |
13,150
-12,250
| -48% | -$334K |
|
1091
Arcutis Biotherapeutics
ARQT
$2.06B
| $358K | ﹤0.01% |
+12,400
| New | +$358K |
|
1092
Rhythm Pharmaceuticals
RYTM
$6.78B
| $357K | ﹤0.01% |
12,000
-600
| -5% | -$17.9K |
|
1093
Morningstar
MORN
$10.8B
| $356K | ﹤0.01% |
1,600
| – | – |
|
1094
OneSpan
OSPN
$583M
| $355K | ﹤0.01% |
17,200
-16,050
| -48% | -$331K |
|
1095
Korro Bio
KRRO
$312M
| $354K | ﹤0.01% |
+200
| New | +$354K |
|
1096
Meritage Homes
MTH
$5.89B
| $349K | ﹤0.01% |
8,164
+6,124
| +300% | +$262K |
|
|
ATNX
1097
DELISTED
Athenex, Inc. Common Stock
ATNX
| $349K | ﹤0.01% |
1,595
+700
| +78% | +$153K |
|
1098
Pricesmart
PSMT
$3.38B
| $346K | ﹤0.01% |
+3,791
| New | +$346K |
|
1099
Arcturus Therapeutics
ARCT
$485M
| $343K | ﹤0.01% |
+8,100
| New | +$343K |
|
|
PRVB
1100
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $342K | ﹤0.01% |
+20,000
| New | +$342K |
|